Arindom Pal

595 total citations
20 papers, 414 citations indexed

About

Arindom Pal is a scholar working on Molecular Biology, Pharmaceutical Science and Cancer Research. According to data from OpenAlex, Arindom Pal has authored 20 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 3 papers in Cancer Research. Recurrent topics in Arindom Pal's work include Extracellular vesicles in disease (5 papers), Drug Solubulity and Delivery Systems (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Arindom Pal is often cited by papers focused on Extracellular vesicles in disease (5 papers), Drug Solubulity and Delivery Systems (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Arindom Pal collaborates with scholars based in United States, Czechia and Netherlands. Arindom Pal's co-authors include Rana Rais, Barbara S. Slusher, Mamoun M. Alhamadsheh, Mark R. Miller, Hyun Joo, Carolyn Tallon, William K. Chan, Norman J. Haughey, Ajit G. Thomas and Jinghang Xie and has published in prestigious journals such as Journal of Medicinal Chemistry, Science Advances and Nature Chemical Biology.

In The Last Decade

Arindom Pal

18 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arindom Pal United States 11 286 85 80 48 39 20 414
Hua Jiang China 14 472 1.7× 114 1.3× 81 1.0× 39 0.8× 35 0.9× 49 646
Cristina Andreani Italy 12 330 1.2× 99 1.2× 126 1.6× 30 0.6× 51 1.3× 20 494
Sung-Won Shin South Korea 14 310 1.1× 103 1.2× 111 1.4× 31 0.6× 44 1.1× 24 553
Caterina Bartolacci Italy 11 224 0.8× 77 0.9× 78 1.0× 29 0.6× 28 0.7× 15 345
Ida H. van der Meulen‐Muileman Netherlands 14 291 1.0× 47 0.6× 110 1.4× 66 1.4× 33 0.8× 21 460
Roma Stawikowska United States 11 199 0.7× 102 1.2× 108 1.4× 62 1.3× 43 1.1× 17 416
Qi Huang China 16 287 1.0× 100 1.2× 124 1.6× 18 0.4× 67 1.7× 47 572
Zhenghua Wu China 14 215 0.8× 45 0.5× 91 1.1× 28 0.6× 63 1.6× 40 486
Yingdai Gao China 13 301 1.1× 81 1.0× 86 1.1× 38 0.8× 91 2.3× 42 536

Countries citing papers authored by Arindom Pal

Since Specialization
Citations

This map shows the geographic impact of Arindom Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arindom Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arindom Pal more than expected).

Fields of papers citing papers by Arindom Pal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arindom Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arindom Pal. The network helps show where Arindom Pal may publish in the future.

Co-authorship network of co-authors of Arindom Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Arindom Pal. A scholar is included among the top collaborators of Arindom Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arindom Pal. Arindom Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yi‐Hsien, Arindom Pal, Tycho Heimbach, et al.. (2025). Using Model Master Files to Support Oral Drug Product Development and Regulatory Submissions. Pharmaceutical Research. 42(5). 753–763. 1 indexed citations
2.
Charbe, Nitin B., Abdullah Al Shoyaib, Arindom Pal, et al.. (2025). A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: Paving the road towards fed state virtual BE studies for itraconazole amorphous solid dispersions. European Journal of Pharmaceutical Sciences. 209. 107047–107047. 4 indexed citations
3.
Pal, Arindom, Khondoker Alam, Tycho Heimbach, et al.. (2025). Assessing Impact of Food on Oral Drug Bioequivalence Supporting ICH M13 A with the Advancements of Physiologically Based Pharmacokinetic Modeling. Pharmaceutical Research. 42(5). 835–845.
4.
Shapiro, Rachel, Arindom Pal, David Bartee, et al.. (2024). Investigating inhibitors of 1-deoxy- d -xylulose 5-phosphate synthase in a mouse model of UTI. Microbiology Spectrum. 12(4). e0389623–e0389623. 2 indexed citations
5.
Thomas, Ajit G., Niyada Hin, Lukáš Tenora, et al.. (2023). Neutral sphingomyelinase 2 inhibitors based on the pyrazolo[1,5-a]pyrimidin-3-amine scaffold. European Journal of Medicinal Chemistry. 259. 115674–115674. 2 indexed citations
6.
Tallon, Carolyn, Pragney Deme, Carlos Nogueras‐Ortiz, et al.. (2023). Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model. Translational Neurodegeneration. 12(1). 56–56. 14 indexed citations
7.
Rais, Rana, Kathryn M. Lemberg, Lukáš Tenora, et al.. (2022). Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science Advances. 8(46). eabq5925–eabq5925. 77 indexed citations
8.
Tallon, Carolyn, Anjali Sharma, Arindom Pal, et al.. (2022). Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice. Pharmaceutics. 14(10). 2066–2066. 15 indexed citations
9.
Pal, Arindom, et al.. (2022). Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand. Journal of Medicinal Chemistry. 65(22). 15473–15486. 14 indexed citations
10.
Pal, Arindom, Seung‐Wan Yoo, Ajit G. Thomas, et al.. (2022). Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIP. Journal of Medicinal Chemistry. 65(16). 11111–11125. 12 indexed citations
11.
Thomas, Ajit G., Arindom Pal, Dana Ferraris, et al.. (2022). D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II. Pharmaceutics. 14(10). 2018–2018. 1 indexed citations
12.
Alt, Jesse, Kathryn M. Lemberg, Arindom Pal, et al.. (2021). Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement. Current Drug Metabolism. 22(9). 735–745. 3 indexed citations
13.
Tallon, Carolyn, Kristen R. Hollinger, Arindom Pal, et al.. (2021). Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases. Drug Discovery Today. 26(7). 1656–1668. 35 indexed citations
14.
Tallon, Carolyn, Silvia Picciolini, Seung‐Wan Yoo, et al.. (2021). Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury. Biochemical Pharmacology. 194. 114796–114796. 24 indexed citations
15.
Hin, Niyada, Eva Prchalová, Arindom Pal, et al.. (2021). Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursor. Bioorganic & Medicinal Chemistry Letters. 50. 128321–128321. 3 indexed citations
16.
Pal, Arindom, Fang Liu, Mark R. Miller, et al.. (2019). Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents. Molecular Pharmaceutics. 16(7). 3237–3252. 19 indexed citations
17.
Miller, Mark R., Arindom Pal, Hyun Joo, et al.. (2018). Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis. Journal of Medicinal Chemistry. 61(17). 7862–7876. 66 indexed citations
18.
Miller, Mark R., Arindom Pal, Nikhil Reddy Madadi, et al.. (2015). A biomimetic approach for enhancing the in vivo half-life of peptides. Nature Chemical Biology. 11(10). 793–798. 106 indexed citations
19.
Fawole, Femi J., N.P. Sahu, Arindom Pal, & W. S. Lakra. (2013). Evaluation of antioxidant and antimicrobial properties of selected Indian medicinal plants.. 3(1). 69–77. 4 indexed citations
20.
Pal, Arindom, et al.. (2013). Phytochemical Screening and In vitro Evaluation of Pharmacological Activities of <i>Aphanamixis polystachya</i> (Wall) Parker Fruit Extracts. Tropical Journal of Pharmaceutical Research. 12(1). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Jiang Breakdown of academic impact, for papers by Cristina Andreani Breakdown of academic impact, for papers by Sung-Won Shin Breakdown of academic impact, for papers by Caterina Bartolacci Breakdown of academic impact, for papers by Ida H. van der Meulen‐Muileman Breakdown of academic impact, for papers by Roma Stawikowska Breakdown of academic impact, for papers by Qi Huang Breakdown of academic impact, for papers by Zhenghua Wu Breakdown of academic impact, for papers by Yingdai Gao
Rankless by CCL
2026